X4 Pharmaceuticals, Inc. is a global, late-stage clinical biopharmaceutical company. X4 is a leader in the discovery and development of novel therapies for the treatment of rare diseases of the immune system, including WHIM syndrome and chronic neutropenic disorders. X4 is headquartered in Boston, Massachusetts with a research center of excellence in Vienna, Austria